Joan edukira
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Hizkuntza
Eremu guztiak
Izenburua
Egilea
Gaia
Sailkapena
ISBN/ISSN
Etiketa
Bilatu
Aurreratua
Statin Cost-Effectiveness in t...
Erreferentzia bihurtu
SMS
Bidali
Imprimir
Erregistroa esportatu
Nora RefWorks
Nora EndNoteWeb
Nora EndNote
Permanent link
Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels
Xehetasun bibliografikoak
Egile Nagusiak:
Mihaylova, B
,
Briggs, A
,
Hlatky, M
,
Armitage, J
,
Parish, S
,
Gray, A
,
Collins, R
,
Study, HP
Formatua:
Journal article
Argitaratua:
2009
Aleari buruzko argibideak
Deskribapena
Antzeko izenburuak
MARC erregistroa
Deskribapena
Gaia:
Antzeko izenburuak
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
nork: Mihaylova, B, et al.
Argitaratua: (2005)
Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
nork: Mihaylova, B, et al.
Argitaratua: (2005)
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.
nork: Mihaylova, B, et al.
Argitaratua: (2006)
Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study
nork: Mihaylova, B, et al.
Argitaratua: (2024)
The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
nork: Kent, S, et al.
Argitaratua: (2016)